In this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Arshad M. Khanani, MD, MA, discuss new findings about emerging therapies that target the angiopoietin/Tie2 pathway that may improve the treatment of neovascular retinal diseases. Transcript: https://bit.ly/38jWicU To obtain CME Credit, please go here: <a href= "https://bit.ly/2nBqmhq">https://bit.ly/2nBqmhq</a>

In this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Arshad M. Khanani, MD, MA, discuss new findings about emerging therapies that target the angiopoietin/Tie2 pathway that may improve the treatment of neovascular retinal diseases. Transcript: https://bit.ly/38jWicU To obtain CME Credit, please go here: https://bit.ly/2nBqmhq

In this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Arshad M. Khanani, MD, MA, discuss new findings about emerging therapies that target the angiopoietin/Tie2 pathway that may improve the treatment of neovascular retinal diseases. Transcript: https://bit.ly/38jWicU To obtain CME Credit, please go here:&nbsp;<a href="https://bit.ly/2nBqmhq" rel="noopener noreferrer">https://bit.ly/2nBqmhq</a>&nbsp;

Targeting Treatment in Neovascular Retinal Disease

MedEdTalks Ophthalmology is an accredited educational podcast for providers to learn more about treating patients with Ophthalmology diseases/disorders. Discover all content and topics by visiting mededtalks.com.

Share Targeting Treatment in Neovascular Retinal Disease

Sign up to save your podcasts

Targeting Treatment in Neovascular Retinal Disease

Targeting Treatment in Neovascular Retinal Disease